-
Diagnostics World News | Researchers at Duke University have come up with the new “best-in-class” systemic biomarker predictive of clinically relevant knee osteoarthritis that significantly outperforms the top-rated urine test when it comes to recognizing disease progression. Development of the targeted multiple reaction monitoring proteomic panel has been a 12-year labor of love for the team.
Feb 9, 2023
-
Diagnostics World News | Researchers in Germany have developed a series of innovative solutions for probing the body more broadly and deeply for early pathological signs of diseases ranging from metabolic disorders and neurodegenerative diseases to cancer. Their novel technology, dubbed DISCO-MS, does spatial proteomics in three-dimensional (3D) intact specimens using a combination of whole-organ and whole-organism clearing and imaging, deep-learning-based image analysis, robotic tissue extraction, and ultrahigh-sensitivity mass spectrometry.
Feb 8, 2023
-
Diagnostics World News | Research scientists at Indiana University–Purdue University Indianapolis and Regenstrief Institute have developed a “passive digital marker” (PDM), powered by machine learning, to help identify people at risk for Alzheimer’s disease and related dementias at an earlier stage in primary care settings. Application of the PDM will now be tested in the real world in a pair of pragmatic randomized controlled trials.
Feb 7, 2023
-
Diagnostics World News | Researchers at the Norwegian University of Science and Technology and the University of Notre Dame have developed a new microresonator for biochemical sensing. This is big news, according to Dingding Ren and David Burghoff, co-leaders in joint research between the two institutes.
Feb 2, 2023
-
Diagnostics World News | An international team of neuroscientists expect to soon be handing off development of a promising new blood test for Alzheimer’s disease neurodegeneration to a U.S.-based biomarker company. The immunoassay selectively measures brain-derived tau and was recently demonstrated to outperform both assessments of plasma total tau levels and measurements of neurofilament light chain concentration, a protein marker of nerve cell damage.
Jan 31, 2023